Pharvaris N.V. (PHVS)
NASDAQ: PHVS · Real-Time Price · USD
34.61
-0.71 (-2.01%)
Aug 31, 2026, 4:00 PM EDT - Market closed
Pharvaris Market Cap
Pharvaris has a market cap or net worth of $2.43 billion as of August 31, 2026. Its market cap has increased by 55.22% in one year.
Market Cap
2.43B
Enterprise Value
2.07B
1-Year Change
55.22%
Ranking
Category
Stock Price
$34.61
ChartMarket Cap Chart
Since the IPO on February 5, 2021, Pharvaris's market cap has increased from $636.80M to $2.43B, an increase of 281.56%. That is a compound annual growth rate of 27.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 2.43B | 34.79% |
| Dec 31, 2025 | 1.80B | 73.39% |
| Dec 31, 2024 | 1.04B | -28.87% |
| Dec 29, 2023 | 1.46B | 284.53% |
| Dec 30, 2022 | 380.11M | -20.27% |
| Dec 31, 2021 | 476.72M | -25.14% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SELLAS Life Sciences Group | 2.67B |
| Viridian Therapeutics | 2.61B |
| Ultragenyx Pharmaceutical | 2.52B |
| Precigen | 2.49B |
| Nektar Therapeutics | 2.48B |
| Vera Therapeutics | 2.46B |
| Trevi Therapeutics | 2.39B |
| Kodiak Sciences | 2.37B |